Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management

Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia

(2019) José Perdomo et al.   Nature Communications

A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia

(2019) Nikola Ivetic et al.   PLATELETS

Development of an algorithm for the systematic evaluation of patients with suspected heparin-induced thrombocytopenia

(2019) Julie Thomson et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome

(2019) Elan Mohanty et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Risk of Major Bleeding in Patients with Suspected Heparin‐Induced Thrombocytopenia ( HIT )

(2019) Allyson M. Pishko et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia

(2018) Theodore E. Warkentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument

(2018) Ying Wang et al.   THROMBOSIS RESEARCH

Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia

(2018) B.D. Park et al.   TRANSFUSION AND APHERESIS SCIENCE

Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study

(2018) Binod Dhakal et al.   Lancet Haematology

Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)

(2018) Lubica Rauova et al.   AUTOIMMUNITY REVIEWS

Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia

(2018) Mehraboon Irani et al.   TRANSFUSION

Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia

(2017) Kyle A. Davis et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis

(2017) Zhengwu Sun et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Incidence and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing Vascular Surgery

(2017) Rabail Chaudhry et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia

(2017) Theodore E. Warkentin   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Autoimmune heparin-induced thrombocytopenia

(2017) A. Greinacher et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update

(2017) Emmanuel J. Favaloro et al.   PATHOLOGY

Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review

(2017) Dilli Ram Poudel et al.   PLATELETS

Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients

(2017) Allyson Pishko et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program

(2016) K. E. McGowan et al.   BLOOD

How I treat patients with a history of heparin-induced thrombocytopenia

(2016) T. E. Warkentin et al.   BLOOD

A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis

(2016) Anand Padmanabhan et al.   CHEST

Heparin-Induced Thrombocytopenia

(2016) Benjamin S. Salter et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inappropriate documentation of heparin allergy in the medical record because of misdiagnosis of heparin-induced thrombocytopenia: frequency and consequences

(2016) C. M. McMahon et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study

(2016) L. A. Linkins et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients

(2016) Sixten Selleng et al.   THROMBOSIS AND HAEMOSTASIS

Non-vitamin K antagonist oral anticoagulants for heparin-induced thrombocytopenia. A systematic review of 54 reported cases

(2016) Meg Crapster-Pregont et al.   THROMBOSIS AND HAEMOSTASIS

Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia

(2016) Theodore E. Warkentin   THROMBOSIS AND HAEMOSTASIS

Management of the multiple phases of heparin-induced thrombocytopenia

(2016) Adam Cuker   THROMBOSIS AND HAEMOSTASIS

Heparin-induced thrombocytopenia: research and clinical updates

(2016) O. Onwuemene et al.   Hematology-American Society of Hematology Education Program

The platelet serotonin-release assay

(2015) Theodore E. Warkentin et al.   AMERICAN JOURNAL OF HEMATOLOGY

Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery

(2015) S. Bito et al.   BLOOD

Heparin-induced thrombocytopenia

(2015) Theodore E. Warkentin   Current Opinion in Critical Care

Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages

(2015) Theodore E. Warkentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heparin-Induced Thrombocytopenia

(2015) Andreas Greinacher   NEW ENGLAND JOURNAL OF MEDICINE

Implications of Heparin-Induced Thrombocytopenia Overdiagnosis

(2014) Maureen A. Smythe et al.   ANNALS OF PHARMACOTHERAPY

Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin

(2014) T. E. Warkentin et al.   BLOOD

Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia

(2014) Steven E. McKenzie et al.   CURRENT OPINION IN HEMATOLOGY

Heparin induced thrombocytopaenia (HIT) as a cause of free flap failure in lower limb trauma

(2014) S.R. Zaman et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia

(2014) L. Joseph et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Plasmapheresis May Be an Option in Urgent Management of Heparin-Induced Thrombocytopenia in the Setting of Acute Intracerebral Hemorrhage

(2014) Emitseilu Iluonakhamhe et al.   Neurocritical Care

HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT

(2014) Jo-Ann Sheppard et al.   THROMBOSIS AND HAEMOSTASIS

Atherosclerosis is not a risk factor for antiplatelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery

(2014) Lubica Rauova et al.   THROMBOSIS AND HAEMOSTASIS

Incidence and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing Cardiac Surgery in North America: An Analysis of the Nationwide Inpatient Sample

(2013) Matthew Seigerman et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA

Heparin-induced thrombocytopenia and thrombosis as an under-diagnosed cause of flap failure in heparin-naive patients: A case report and systematic review of the literature

(2013) Oren Tessler et al.   MICROSURGERY

Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis

(2012) A. Cuker et al.   BLOOD

How I treat heparin-induced thrombocytopenia

(2012) A. Cuker et al.   BLOOD

Treatment and Prevention of Heparin-Induced Thrombocytopenia

(2012) Lori-Ann Linkins et al.   CHEST

The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome

(2012) Anup K. Chakraborty et al.   THROMBOSIS AND HAEMOSTASIS

Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease

(2011) A. Greinacher et al.   BLOOD

Bilateral adrenal hemorrhage: The unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia*

(2011) Laura H. Rosenberger et al.   CRITICAL CARE MEDICINE

Platelet Factor 4/Heparin Antibodies in Blood Bank Donors

(2010) Marcie J. Hursting et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia

(2010) K. Krauel et al.   BLOOD

The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion

(2010) A. CUKER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin-Induced Thrombocytopenia Leading to Flap Failure: Hirudo medicinalis and Implications

(2010) Nilton D. Medina et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Heparin/PF4 antibodies formation after heparin treatment: Temporal aspects and long-term follow-up

(2009) Anna Vittoria Mattioli et al.   AMERICAN HEART JOURNAL

Plasmapheresis and Heparin Reexposure as a Management Strategy for Cardiac Surgical Patients with Heparin-Induced Thrombocytopenia

(2009) Ian J. Welsby et al.   ANESTHESIA AND ANALGESIA

Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive

(2009) S. SELLENG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital

(2009) Makiko Ban-Hoefen et al.   THROMBOSIS RESEARCH

Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation

(2008) S. Selleng et al.   BLOOD

Treatment and Prevention of Heparin-Induced Thrombocytopenia

(2008) Theodore E. Warkentin et al.   CHEST

Complete salvage of impending free flap failure in heparin induced thrombocytopenia by emergent institution of therapy with argatroban

(2008) Arno R. Schleich et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Heparin-induced thrombocytopenia syndrome as a cause of flap failure: A report of two cases

(2007) Dominique M. Tremblay et al.   Journal of Plastic Reconstructive and Aesthetic Surgery